Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ADRB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C3orf49 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
OVOL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIMK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ABCG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSSK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUBB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NIPSNAP3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNAQ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUFU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EDN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C9orf38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GDAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC105374768 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLCE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on